Achondroplasia

Achondroplasia is the most common skeletal dysplasia and the most prevalent form of dwarfism, caused by autosomal dominant mutations in the fibroblast growth factor receptor 3 (FGFR3) gene that result in disproportionate short stature with characteristic skeletal deformities. The condition affects approximately 1 in 25,000 live births worldwide, with equal gender distribution, and approximately 80% of cases represent new mutations occurring in the paternal germline. Clinical significance is substantial because affected individuals present across the lifespan with complications ranging from spinal stenosis and neurological compression in adulthood to potential fatal complications such as foramen magnum stenosis and sudden infant death in infancy. Understanding achondroplasia is essential for medical students and board candidates because it exemplifies a paradigm of gain-of-function mutations in growth factor signaling, requires multidisciplinary management, and frequently appears as a clinical vignette on standardized examinations.

Achondroplasia results from a point mutation in FGFR3, most commonly affecting nucleotide 1138 in exon 10 (resulting in G380R substitution in ~80% of familial cases) or nucleotide 1136 in exon 10. This gain-of-function mutation causes constitutive activation of the tyrosine kinase receptor independent of ligand binding. The mutated receptor remains in a hyperphosphorylated, activated state, resulting in unregulated and excessive signaling through downstream pathways including the MAPK (mitogen-activated protein kinase) cascade and phosphoinositide 3-kinase (PI3K) pathway. This aberrant signaling amplifies inhibitory signals that normally regulate endochondral ossification, paradoxically suppressing rather than promoting bone growth—a counterintuitive mechanism where "more signal" leads to less bone formation.

In normal endochondral ossification, chondrocytes in the growth plate progress through a tightly regulated sequence: resting zone → proliferative zone → hypertrophic zone → apoptosis and mineralization. FGFR3 signaling, even at normal levels, serves as a brake on this progression. In achondroplasia, hyperactive FGFR3 signaling accelerates the exit of chondrocytes from the proliferative phase into premature differentiation and hypertrophy. Simultaneously, the pathway suppresses proliferation itself by increasing expression of p21 and p27 (CDK inhibitors), effectively creating a double hit: reduced proliferation combined with accelerated terminal differentiation. This results in fewer rounds of cell division in the proliferative zone, dramatically reducing the vertical height of the growth plate and thus longitudinal bone growth. The mechanism explains why the growth defect is most severe in long bones where endochondral ossification is the primary growth mechanism.

Different skeletal regions respond to the FGFR3 signal with varying intensity. Long bones of the extremities (femur, humerus, tibia) show the most dramatic growth restriction because they rely heavily on endochondral ossification through extensive growth plate activity. In contrast, bones formed primarily through intramembranous ossification (skull vault, facial bones) show relatively preserved or only mildly reduced growth. This differential response explains the characteristic body proportions: markedly shortened limbs (rhizomelic shortening, particularly in proximal segments) with relatively preserved trunk length. The sacroiliac joints and spinal canal also undergo abnormal development due to reduced growth of vertebral bodies and posterior elements.

Contrary to intuition, skeletal maturity in achondroplasia is actually delayed relative to height. Growth plates remain open longer than in unaffected individuals, but the growth rate is so substantially reduced that final height is reached at a later chronological age. The growth hormone and insulin-like growth factor-1 (IGF-1) axes are functionally normal—circulating levels are typically unremarkable, and these patients do not respond to growth hormone therapy. Instead, the fundamental defect is in the responsiveness of chondrocytes to mitogenic and anabolic signals. The growth plates eventually do fuse, typically by the second to third decade of life, because the FGFR3 pathway drives terminal differentiation, which ultimately leads to growth arrest.

The vertebral bodies develop with reduced height due to the same endochondral ossification defect affecting long bones. Additionally, the posterior elements (laminae, spinous processes) may develop normally or even show relative overgrowth in some cases, creating a paradoxical narrowing of the spinal canal. The ligamentum flavum may thicken with age due to fibrosis. These factors combine to produce progressive spinal canal stenosis, particularly in the lumbar spine—a complication that becomes increasingly prevalent and symptomatic from the third to fifth decades of life. The narrowing is anatomically compounded by the shortened pedicles and reduced interpedicular distance characteristic of achondroplastic vertebrae.

The single etiology of achondroplasia is a point mutation in FGFR3. Most commonly (approximately 80% of familial and new cases), this is a G→A transition at nucleotide 1138 (c.1138G>A) resulting in the glycine-to-arginine substitution at codon 380 (p.Gly380Arg). Less frequently, mutations occur at nucleotide 1136 (c.1136G>A, p.Gly380Arg via different nucleotide change), accounting for the remaining familial cases. Approximately 80% of all achondroplasia cases result from new mutations (de novo) rather than inheritance, making family history negative in the vast majority of index cases. The de novo mutations show a strong paternal origin bias, with 99% of new mutations occurring in the paternal germline, suggesting either selective advantage during spermatogenesis or higher mutation rate during DNA replication in older sperm-producing cells (the "paternal age effect").

The most significant identified risk factor for de novo achondroplasia is advanced paternal age. Multiple studies demonstrate a linear increase in achondroplasia incidence with paternal age, with the relative risk increasing exponentially—fathers over 50 years old have approximately a 2-fold increased risk compared to fathers under 30 years. This phenomenon suggests that the FGFR3 mutation arises during male gametogenesis, potentially due to selective expansion of spermatogonial clones harboring the mutation or increased mutation rate with advancing paternal age. This represents one of the clearest examples of a paternal age effect in human genetics and is an important teaching point about mutagenesis in aging males.

For individuals with an affected parent, the inheritance follows autosomal dominant transmission with virtually complete penetrance—approximately 50% of offspring from an affected parent will inherit the mutation. Approximately 20% of achondroplasia cases are inherited from an affected parent. Homozygous achondroplasia (inheriting the FGFR3 mutation from both parents) is extremely rare but uniformly fatal in utero or early infancy due to severe skeletal dysplasia and thoracic hypoplasia incompatible with life.

Unlike some genetic conditions, achondroplasia shows no clear association with maternal age, maternal exposures, environmental toxins, or nutritional factors. The condition occurs with equal frequency across all ethnic groups and socioeconomic backgrounds. Prenatal factors do not influence disease severity—severity is determined entirely by the germline mutation inherited or acquired.

The hallmark clinical presentation is severe short stature with disproportionate involvement of the proximal limbs (rhizomelic) relative to distal limbs and trunk. Adult height typically ranges from 4 feet (120 cm) in females to 4 feet 4 inches (132 cm) in males—approximately 20-30 cm below expected height for the general population. The shortening is most pronounced in the femur and humerus (proximal long bones), creating a body proportion where the sitting height is relatively preserved but the limb-to-trunk ratio is dramatically reduced. Infants present with short limbs relative to crown-rump length, which becomes increasingly apparent with growth and can be detected by trained personnel on newborn examination. By early childhood, the disproportionate appearance becomes unmistakable, with characteristic "short arms and legs" appearance relative to trunk size.

The distinctive facial features reflect abnormal development of endochondral bone, particularly the skull base and mid-face. Classic findings include frontal bossing (prominent forehead due to excessive growth of the frontal bone in the intramembranous ossification pathway), mid-face hypoplasia (flattened nasal bridge and underdeveloped maxilla), and relative mandibular prognathism (prominence of the lower jaw relative to the upper face). The nasal bridge appears sunken or saddle-shaped in some patients. Patients typically have normal intelligence with normal intellectual development, and the specific facial features themselves are not associated with developmental delay. The combination of frontal bossing and mid-face hypoplasia creates a distinctive profile that experienced clinicians recognize immediately.

Physical examination reveals several characteristic extremity findings beyond simple shortness. The arms cannot reach the midline of the thighs when extended, a finding that contrasts sharply with unaffected individuals whose fingertips typically reach the mid-thigh or below. Genu varum (bowlegs) develops in approximately 60% of children and may progress during growth, occasionally requiring surgical intervention if severe. Some patients develop genu valgum instead. Ligamentous laxity is common, contributing to increased joint mobility in some joints while paradoxically producing joint stiffness in others. The hands show characteristic findings including short fingers with relatively preserved thumb (distinguishing this from other skeletal dysplasias), often with mild syndactyly (webbing) between digits 3 and 4. Patients may demonstrate the trident hand (splaying of fingers 3-5 when extended, creating a three-pronged appearance), though this is neither sensitive nor specific.

Spinal involvement occurs to varying degrees throughout life. Thoracolumbar kyphosis (excessive forward curvature) is common in infancy and early childhood, often resolving spontaneously by early school age but sometimes persisting. Lumbar lordosis (excessive inward curvature) develops during childhood and adolescence and tends to progress with age. Limitation of hip and knee extension is nearly universal, contributing to a characteristic gait pattern with flexed knees. Hypermobility of spinal joints may develop due to ligamentous laxity, creating instability. Most significantly, spinal stenosis (narrowing of the spinal canal) develops progressively, with lumbar stenosis being most common. Neurological symptoms from stenosis typically emerge in the third to fifth decades of life and include claudication (leg pain with walking that improves with rest), paresthesias, and potential myelopathic features. Cervical stenosis at the foramen magnum level is less common but has the potential for more serious consequences.

Narrowing of the foramen magnum where the spinal cord exits the skull occurs due to underdevelopment of the skull base and abnormal vertebral development. This is a life-threatening complication in some infants and young children, presenting with central apnea, sudden infant death, upper extremity weakness, or myelopathic features. The prevalence of clinically significant foramen magnum stenosis is approximately 5-15% of infants and young children with achondroplasia, though anatomic stenosis is more common. This complication necessitates careful pediatric neurological monitoring and may require surgical intervention.

Dental crowding occurs due to mid-face hypoplasia with relatively normal tooth development, potentially requiring orthodontic intervention. Conductive hearing loss develops in 50-75% of achondroplastic individuals due to Eustachian tube dysfunction and recurrent otitis media, related to abnormal development of the temporal bone and skull base structures. Some patients develop mixed hearing loss with both conductive and sensorineural components. Audiological evaluation and management are important aspects of longitudinal care.

A milder clinical phenotype with mutations at different FGFR3 locations (most commonly c.1620C>A in exon 13, p.Asn540Lys) produces hypochondroplasia, characterized by proportionate or only mildly disproportionate short stature, height typically in the low-normal range (120-150 cm), and minimal skeletal deformities. These individuals may escape diagnosis in childhood if the condition is not actively sought. The prognosis is generally better with fewer neurological complications, though spinal stenosis can still develop.

While technically distinct, thanatophoric dysplasia results from different FGFR3 mutations (most commonly c.742C>T, p.Arg248Cys in exon 7) and produces a much more severe phenotype with severe micromelia (extremely shortened limbs), narrow thorax, and severe vertebral abnormalities. Affected fetuses typically die in utero or within hours of birth due to severe respiratory insufficiency from thoracic hypoplasia.

Achondroplasia is fundamentally a clinical diagnosis in most cases, based on recognition of the characteristic constellation of clinical features: disproportionate short stature with rhizomelic shortening, characteristic facies with frontal bossing and mid-face hypoplasia, and specific extremity findings including shortened arms that don't reach the thigh, genu varum, and trident hands. Experienced clinicians can diagnose achondroplasia confidently in infancy or early childhood through clinical recognition alone. The diagnosis should be suspected in any infant or young child presenting with disproportionate short stature and should be confirmed with molecular or imaging studies.

Plain radiography demonstrates multiple characteristic findings that support the clinical diagnosis. Skeletal survey is the traditional diagnostic imaging study, though not always necessary when clinical features are diagnostic. Classic radiographic findings include:

Lumbar spine imaging frequently shows mild stenosis on initial studies, which may progress asymptomatically for years before becoming clinically symptomatic.

FGFR3 gene sequencing definitively confirms achondroplasia by identifying the characteristic mutation. This is particularly useful when:

Direct DNA sequencing detects >99% of FGFR3 mutations in achondroplasia. Most laboratories use targeted sequencing focusing on exons 7-10 where the vast majority of pathogenic mutations occur. The specific mutation identified (G380R vs. others) does not substantially alter phenotype or prognosis.

Achondroplasia can be suspected prenatally through ultrasound findings beginning in the second trimester: